• Price to earnings forward of Adaptimmune Therapeutics plc – OTC:ADAPY TradingView Mon, 06 Jul 2026 08:24:30 GMT
• adaptimmune therapeutics plc (adap) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 25 Jun 2026 00:43:43 GMT
• adaptimmune therapeutics plc (adap) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 19 Jun 2026 17:48:24 GMT
• adaptimmune therapeutics plc (adap) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 05:33:59 GMT
• adaptimmune therapeutics plc (adap) institutional confidence TradingKey Thu, 18 Jun 2026 02:00:39 GMT
• adaptimmune therapeutics plc (adap) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 01:23:48 GMT
• adaptimmune therapeutics plc (adap) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 01:23:33 GMT
• adaptimmune therapeutics plc (adap) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 01:21:41 GMT
• adaptimmune therapeutics plc (adap) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 01:19:36 GMT
• adaptimmune therapeutics plc (adap) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 22:53:49 GMT
• adaptimmune therapeutics plc (adap) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 22:50:15 GMT
• adaptimmune’s afpᶜ³³²t liver cancer trial posts final phase 1 results: what investors should know TipRanks Wed, 17 Jun 2026 07:00:00 GMT
• adaptimmune therapeutics plc - american depositary shares (nq: adap The Chronicle-Journal Mon, 18 May 2026 19:59:58 GMT
• hc wainwright & co. downgrades adaptimmune therapeutics plc - depositary receipt () (adap) MSN Mon, 18 May 2026 03:12:01 GMT
• adapy sec filings - adaptimmune therapeutics plc 10-k, 10-q, 8-k forms Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• adaptimmune therapeutics plc: fundamental analysis and financial ratings | | us00653a1079 marketscreener.com Fri, 20 Mar 2026 02:48:18 GMT
• adap sec filings - adaptimmune therapeutics plc 10-k, 10-q, 8-k forms Stock Titan Thu, 19 Mar 2026 11:25:30 GMT
• Rare cancer therapy arrives at UIHC, Iowa’s only medical center offering it The Daily Iowan Tue, 10 Mar 2026 07:00:00 GMT
• adap financials: income statement, balance sheet & cash flow Stock Titan Tue, 03 Mar 2026 02:17:05 GMT
• adap financials: income statement, balance sheet & cash flow Stock Titan Thu, 26 Feb 2026 21:31:16 GMT
• adap - adaptimmune therapeutics plc latest stock news & market updates Stock Titan Sun, 22 Feb 2026 20:46:19 GMT
• momentum shift: will adaptimmune therapeutics plc (common stock) (473a) stock announce a stock split - july 2025 update & free saf... mfd.ru Fri, 20 Feb 2026 05:39:33 GMT
• adapy sec filings - adaptimmune therapeutics plc 10-k, 10-q, 8-k forms Stock Titan Tue, 17 Feb 2026 08:00:00 GMT
• long focus capital shows 0% adaptimmune (adapy) ads ownership in 13g Stock Titan Tue, 17 Feb 2026 08:00:00 GMT
• adapy financials: income statement, balance sheet & cash flow stocktitan.net Sat, 14 Feb 2026 23:52:27 GMT
• adap financials: income statement, balance sheet & cash flow Stock Titan Sat, 14 Feb 2026 05:10:24 GMT
• a navy yard biotech is selling its first-of-its-kind therapy for rare cancer, along with other assets MSN Fri, 23 Jan 2026 15:50:04 GMT
• adaptimmune’s final chapter: a stock’s struggle for survival Ad-hoc-news.de Sun, 18 Jan 2026 08:00:00 GMT
• experience real-time quotes, in-depth charts, and analyst ratings webull.com Sat, 17 Jan 2026 02:14:01 GMT
• flagship pioneering appoints adrian rawcliffe as ceo-partner and ceo of etiome citybiz Thu, 08 Jan 2026 08:00:00 GMT
• gene therapy market is going to boom worldwide | glaxosmithkline openPR.com Mon, 05 Jan 2026 06:16:10 GMT
• adaptimmune secures up to $125 million debt financing with hercules capital TMX Newsfile Tue, 23 Dec 2025 17:22:07 GMT
• adaptimmune therapeutics plc (adapy) stock, price, news, quotes, forecast and insights MSN Wed, 10 Dec 2025 13:57:23 GMT
• a complete list of all publicly announced rmat designations (148) BioInformant Wed, 10 Dec 2025 08:00:00 GMT
• adaptimmune therapeutics earnings preview: recent $adap insider trading, hedge fund activity, and more Quiver Quantitative Fri, 05 Dec 2025 08:00:00 GMT
• immunotherapy drugs research report 2025: $526.5 bn market GlobeNewswire Fri, 05 Dec 2025 08:00:00 GMT
• cancer gene therapy market is expected to reach us$ 19.97 billion openPR.com Thu, 04 Dec 2025 10:13:17 GMT
• why adaptimmune therapeutics plc (common stock) (473a) stock is a strong buy call - 2025 major catalysts & safe capital growth pla... Newser Tue, 02 Dec 2025 11:52:19 GMT
• why analysts maintain buy rating on adaptimmune therapeutics plc (common stock) (473a) stock - market activity summary & entry poi... Newser Tue, 02 Dec 2025 06:34:55 GMT
• pd-1 resistant head and neck cancer market research report GlobeNewswire Tue, 25 Nov 2025 08:00:00 GMT
• What is the current Price Target and Forecast for Adaptimmune Therapeutics (ADAPY) Zacks Investment Research Sun, 23 Nov 2025 05:47:58 GMT
• adaptimmune therapeutics (adapy) free cash flow (ttm) Zacks Investment Research Sun, 23 Nov 2025 05:24:35 GMT
• adaptimmune therapeutics (adapy) eps diluted Zacks Investment Research Sun, 23 Nov 2025 05:24:07 GMT
• adaptimmune therapeutics (adapy) cash from investing (quarterly) Zacks Investment Research Sun, 23 Nov 2025 05:16:59 GMT
• adaptimmune therapeutics (adapy) total liabilities Zacks Investment Research Sun, 23 Nov 2025 05:16:07 GMT
• adaptimmune therapeutics (adapy) price to cash flow Zacks Investment Research Sun, 23 Nov 2025 04:51:55 GMT
• adaptimmune therapeutics (adapy) debt equity ratio (quarterly) Zacks Investment Research Sun, 23 Nov 2025 04:48:41 GMT
• adaptimmune therapeutics (adapy) market cap Zacks Investment Research Sat, 22 Nov 2025 22:11:15 GMT
• what is the current price target and forecast for adaptimmune therapeutics (adapy) Zacks Investment Research Sat, 22 Nov 2025 22:04:48 GMT
• what date does adaptimmune therapeutics's (adapy) report earnings - earnings calendar & announcement Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) dividend yield (ttm) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) return on equity (ttm) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) cash from financing (quarterly) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) profit margin (quarterly) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) cash from operations (ttm) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) price to free cash flow Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) return on assets (ttm) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) total assets (quarterly) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) free cash flow (quarterly) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) shareholders equity (quarterly) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) gross profit (ttm) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) book value Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) total expenses (quarterly) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) net income (quarterly) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) enterprise value Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) book value (per share) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) earnings yield (ttm) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) net income (ttm) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) cash equivalents (quarterly) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) revenue (quarterly) yoy growth Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adapy: adaptimmune therapeutics - interactive chart Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• adaptimmune therapeutics (adapy) revenue (ttm) Zacks Investment Research Fri, 21 Nov 2025 20:59:00 GMT
• how adaptimmune therapeutics plc (common stock) (473a) stock responds to job market shifts - portfolio value report & risk control... newser.com Fri, 21 Nov 2025 12:04:27 GMT
• does adaptimmune therapeutics plc (common stock) (473a) stock trade below intrinsic value - 2025 geopolitical influence & real-tim... newser.com Fri, 21 Nov 2025 08:24:44 GMT
• how adaptimmune therapeutics plc (common stock) (473a) stock trades in high volatility - earnings risk report & verified trade ide... newser.com Thu, 20 Nov 2025 04:42:04 GMT
• does adaptimmune therapeutics plc (common stock) (473a) stock trade below intrinsic value - 2025 technical overview & reliable bre... newser.com Thu, 20 Nov 2025 03:30:47 GMT
• why adaptimmune therapeutics plc (common stock) (473a) stock is a strong buy call - earnings risk report & consistent profit focus... newser.com Wed, 19 Nov 2025 19:32:32 GMT
• how adaptimmune therapeutics plc (common stock) (473a) stock compares with market leaders - 2025 geopolitical influence & accurate... newser.com Wed, 19 Nov 2025 09:42:43 GMT
• does adaptimmune therapeutics plc (common stock) (473a) stock trade below intrinsic value - 2025 historical comparison & stepwise ... newser.com Wed, 19 Nov 2025 07:00:32 GMT
• does adaptimmune therapeutics plc (common stock) (473a) stock trade below intrinsic value - 2025 technical patterns & real-time bu... newser.com Tue, 18 Nov 2025 22:41:33 GMT
• adaptimmune therapeutics plc (nasdaq:adap) q4 2024 earnings call transcript MSN Tue, 18 Nov 2025 16:24:22 GMT
• adaptimmune therapeutics plc (adapy) analyst insights, price targets and recommendations Yahoo Finance Australia Tue, 18 Nov 2025 13:40:13 GMT
• how adaptimmune therapeutics plc (common stock) (473a) stock trades in high volatility - portfolio risk summary & stock market tim... newser.com Tue, 18 Nov 2025 11:39:24 GMT
• why adaptimmune therapeutics plc (common stock) (473a) stock is a strong buy call - market volume summary & target return focused ... newser.com Tue, 18 Nov 2025 11:12:12 GMT
• adapy sec filings - adaptimmune therapeutics plc 10-k, 10-q, 8-k forms Stock Titan Tue, 18 Nov 2025 06:38:45 GMT
• how adaptimmune therapeutics plc (common stock) (473a) stock compares with market leaders - 2025 bull vs bear & daily entry point ... newser.com Mon, 17 Nov 2025 20:51:17 GMT
• why adaptimmune therapeutics plc (common stock) (473a) stock is a strong buy call - 2025 earnings surprises & verified entry point... newser.com Mon, 17 Nov 2025 08:47:49 GMT
• Adaptimmune Announces Changes to Board and Executive Leadership Team TMX Newsfile Mon, 17 Nov 2025 08:00:00 GMT
• Adaptimmune Therapeutics Plc (ADAPY) Stock Price, News & Analysis Stock Titan Mon, 17 Nov 2025 08:00:00 GMT
• latest adapy news - adaptimmune announces changes to board and... stocktitan.net Mon, 17 Nov 2025 08:00:00 GMT
• adaptimmune (otc: adapy) appoints chris hill ceo as alleva named chairman stocktitan.net Mon, 17 Nov 2025 08:00:00 GMT
• adaptimmune therapeutics plc (adapy) options chain Yahoo! Finance Canada Mon, 17 Nov 2025 05:34:31 GMT
• why adaptimmune therapeutics plc (common stock) (473a) stock is a strong buy call - analyst downgrade & community consensus stock ... newser.com Sun, 16 Nov 2025 17:45:41 GMT
• why adaptimmune therapeutics plc (common stock) (473a) stock is a strong buy call - july 2025 rallies & stepwise entry/exit trade ... newser.com Sat, 15 Nov 2025 09:29:13 GMT
• what is an rmat? list of publicly announced rmat designations (147) BioInformant Fri, 14 Nov 2025 08:00:00 GMT
• what drives adaptimmune therapeutics plc common stock 473a stock price - volatility adjusted trading & minimal investment capital earlytimes.in Fri, 14 Nov 2025 07:29:17 GMT
• why adaptimmune therapeutics plc (common stock) (473a) stock is a strong buy call - market sentiment report & community trade idea... newser.com Fri, 14 Nov 2025 05:24:32 GMT
Adaptimmune Therapeutics plc(NASDAQ:ADAP)

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to ide...
Website: http://www.adaptimmune.com
Full Time Employees: 420
Sector: Healthcare
Industry: Biotechnology
